Literature DB >> 6392400

Biochemical and immunohistochemical characterization of proteins in Hürthle cell carcinoma.

L De Keyser, L Layfield, A Van Herle, A Costin, K Lewin.   

Abstract

The present study reports the biochemical and immunohistochemical findings in the cytosol of a Hürthle cell carcinoma as compared with that of normal thyroid tissue. Sephadex G-200 chromatography of the extract derived from a Hürthle cell carcinoma and from normal thyroid tissue revealed three identical pools. Pool I consisted mainly of thyroglobulin (Tg), pool II corresponded to albumin, while pool III contained unidentified low molecular weight fragments which could not be studied further. Hürthle cell carcinoma, pool I, had a Tg content of 12.9 micrograms Tg/mg equivalent tissue and a 127I content of 5,6 mole/mole of Tg. Its sialic acid content was undetectable, however. In pool I of the normal thyroid gland, the respective values were 62.8 micrograms Tg/mg equivalent tissue, 21.3 +/mole 127I/mole Tg, and 15.4 mole sialic acid/mole Tg. The albumin contained in both pools II was shown to be ioidinated at the following levels: 0.025 mole 127I/mole albumin in Hürthle tumor pool II vs 1.28 mole 127I/mole albumin in normal thyroid pool II. Immunohistochemical studies confirmed the presence of Tg and albumin in the malignant Hürthle cells and acini and colloid. Thus, Hürthle cell carcinoma contained Tg and albumin. The Tg content was five times less compared with control tissue. Both proteins (Tg and albumin) were poorly iodinated in Hürthle carcinoma tissue, and the iodination of albumina seemed to be more severely impaired. The site of synthesis of both proteins could not be derived from the present studies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392400     DOI: 10.1007/BF03348449

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  PROTEIN-BOUND IODINE, TOTAL IODINE, AND BUTANOL-EXTRACTABLE IODINE BY PARTIAL AUTOMATION.

Authors:  J BENOTTI; N BENOTTI
Journal:  Clin Chem       Date:  1963-08       Impact factor: 8.327

2.  Human thyroid tumors composed of mitochondrion-rich cells: electron microscopic and biochemical findings.

Authors:  L J Valenta; M Michel-Bechet; J B Warshaw; F Maloof
Journal:  J Clin Endocrinol Metab       Date:  1974-10       Impact factor: 5.958

3.  Oxyphilic adenoma of the human thyroid. A morphological and biochemical study.

Authors:  P Heimann; J G Ljunggren; T Löwhagen; B Hjern
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

4.  Hürthle cell lesions of the thyroid gland.

Authors:  N W Thompson; E L Dunn; J G Batsakis; R H Nishiyama
Journal:  Surg Gynecol Obstet       Date:  1974-10

5.  Ultrastructure of three Hürthle cell tumors of the thyroid.

Authors:  P S Feldman; E Horvath; K Kovacs
Journal:  Cancer       Date:  1972-11       Impact factor: 6.860

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Thyroid albumin. I. Isolation and purification.

Authors:  M H Jonckheer; D M Karcher
Journal:  J Clin Endocrinol Metab       Date:  1971-01       Impact factor: 5.958

8.  Cyanogen bromide fragments of human serum albumin.

Authors:  R H McMenamy; H M Dintzis; F Watson
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

9.  Defective thyroglobulin synthesis in an experimental rat thyroid tumor: iodination and thyroid hormone synthesis in isolated tumor thyroglobulin.

Authors:  F Monaco; S Grimaldi; R Dominici; J Robbins
Journal:  Endocrinology       Date:  1975-08       Impact factor: 4.736

10.  Oxyphil tumors of the thyroid: follow-up of 42 surgical cases.

Authors:  L Bondeson; A G Bondeson; O Ljungberg; S Tibblin
Journal:  Ann Surg       Date:  1981-12       Impact factor: 12.969

View more
  1 in total

1.  Oxyphil cells in thyroid disease: a uniform change?

Authors:  C H Kendall; E McCluskey; J N Meagles
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.